Luciw v. Chang.

Counsel for the National Institutes of Health in a patent interference against Novartis/Chiron involving first-generation HIV-1 hybridization assays. Obtained judgment of priority for client. Confirmed on appeal. Patent Interference No. 105,291 (USPTO).

Attorneys

Services